Emilie leads the Outcomes Research Team and business at Tempus and represents Tempus on the Real World Evidence Alliance. Emilie was previously the Global Director of Health Economics and Outcomes Research at Seagen. She has worked in biopharma (Amgen, Merck, Seagen, Pfizer) for a decade in roles across HEOR, RWE, and market access. She has extensive knowledge in designing and executing non-interventional, observational research studies for external dissemination (40+ publications) and regulatory submissions. Emilie earned an undergraduate degree from USC and a Masters in Health Economics from the London School of Economics / LSHTM.

Session:

• Leveraging Real-World Data for Next-Generation Clinical Trial Design